Matches in Nanopublications for { ?s ?p "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP407455.RAEx6rCfjEPMhnTb-4-YQn8x6ktxs0AfoxIa7ohl9xaHQ130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407455.RAEx6rCfjEPMhnTb-4-YQn8x6ktxs0AfoxIa7ohl9xaHQ130_provenance.
- NP337804.RA_tvH6aHjdQ9tBc3kkRYT-0tqwtrh-CAIDoSUv8UrwWI130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP337804.RA_tvH6aHjdQ9tBc3kkRYT-0tqwtrh-CAIDoSUv8UrwWI130_provenance.
- NP189592.RA33EY0zEO9NPFessX2lToc0xs2XbtgnS6I7Wgq_PR8-s130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189592.RA33EY0zEO9NPFessX2lToc0xs2XbtgnS6I7Wgq_PR8-s130_provenance.
- NP214357.RA2480GC7VMTjJy490qDaUvSLu4vGcYuSaBaz-jqjNyOU130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP214357.RA2480GC7VMTjJy490qDaUvSLu4vGcYuSaBaz-jqjNyOU130_provenance.
- NP881565.RACypsJoForRd-PCqo8gdyLg7FMiXaP8N6ys9XyMu5Yc0130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881565.RACypsJoForRd-PCqo8gdyLg7FMiXaP8N6ys9XyMu5Yc0130_provenance.
- NP615431.RATefXfRMfqkOAz66Iqf2H4FdkASd58GMrmbbN5kuZRKQ130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615431.RATefXfRMfqkOAz66Iqf2H4FdkASd58GMrmbbN5kuZRKQ130_provenance.
- NP615440.RAx3H26DFzkc5fGGUEVvUAmdVDisOlmgF1brwEOiRQrck130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615440.RAx3H26DFzkc5fGGUEVvUAmdVDisOlmgF1brwEOiRQrck130_provenance.
- NP881566.RA54KdsswmJFZtJ-KGw_wECUvhiomzOiACkLSTrytKkp0130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881566.RA54KdsswmJFZtJ-KGw_wECUvhiomzOiACkLSTrytKkp0130_provenance.
- NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881564.RASPrkaIKG0OQ-u6laKZsuIigcTTvHulhLMsIJAcTl9ws130_provenance.
- NP881567.RASkg8eGIxgFLZVn3vagaFNtKPKATc8OLvPlf-QTHpksI130_assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881567.RASkg8eGIxgFLZVn3vagaFNtKPKATc8OLvPlf-QTHpksI130_provenance.
- assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[After subcutaneous administration to mice bearing human prostate cancer PC-3 xenografts, ACA (6 mg/kg/day) remarkably inhibited tumor volume and tumor weight and decreased levels of Src, CD31, VEGF and Ki-67.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.